1
|
Nassar A, Conticchio M, Lardinois MJ, Benedetti J, Lartigau L, Marchese U, Tzedakis S, Fuks D. [Prophylactic surgery for hepatic and biliary tumors]. Bull Cancer 2024:S0007-4551(24)00194-2. [PMID: 38937178 DOI: 10.1016/j.bulcan.2024.04.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2024] [Revised: 04/21/2024] [Accepted: 04/24/2024] [Indexed: 06/29/2024]
Abstract
Benign tumors of the liver and biliary tract are rare entities, and some of them require surgical management to prevent their malignant transformation. Tumors from the biliary tract with malignant potential are treated either by hepatic resection, for mucinous cystic neoplasm and ciliated hepatic foregut cysts, or by biliary resections, for biliary papillary neoplasm and type I and IV choledochal cysts. The pathologies requiring prophylactic cholecystectomy are polyps larger than 10 mm, porcelain gallbladder and pancreaticobiliary maljunction. Finally, hepatocellular adenoma over 5cm, occurring in male patients, or exon 3 mutated beta-catenin, should lead to prophylactic resection by hepatic segmentectomy. This article describes these different pathologies and their management.
Collapse
Affiliation(s)
- Alexandra Nassar
- Service de chirurgie digestive, hépatobiliaire et endocrinienne, hôpital Cochin, AP-HP Centre, université Paris Cité, Paris, France.
| | - Maria Conticchio
- Service de chirurgie digestive, hépatobiliaire et endocrinienne, hôpital Cochin, AP-HP Centre, université Paris Cité, Paris, France
| | - Marie-Julie Lardinois
- Service de chirurgie digestive, hépatobiliaire et endocrinienne, hôpital Cochin, AP-HP Centre, université Paris Cité, Paris, France
| | - Juliette Benedetti
- Service de chirurgie digestive, hépatobiliaire et endocrinienne, hôpital Cochin, AP-HP Centre, université Paris Cité, Paris, France
| | - Lisa Lartigau
- Service de chirurgie digestive, hépatobiliaire et endocrinienne, hôpital Cochin, AP-HP Centre, université Paris Cité, Paris, France
| | - Ugo Marchese
- Service de chirurgie digestive, hépatobiliaire et endocrinienne, hôpital Cochin, AP-HP Centre, université Paris Cité, Paris, France
| | - Stylianos Tzedakis
- Service de chirurgie digestive, hépatobiliaire et endocrinienne, hôpital Cochin, AP-HP Centre, université Paris Cité, Paris, France
| | - David Fuks
- Service de chirurgie digestive, hépatobiliaire et endocrinienne, hôpital Cochin, AP-HP Centre, université Paris Cité, Paris, France.
| |
Collapse
|
2
|
Zhao L, Zhou Y, Ding J, Qin Z, Zhou H, Jing X. Primary hepatic squamous cell carcinoma: case report and systematic review of the literature. Front Oncol 2023; 13:1229936. [PMID: 38239651 PMCID: PMC10795173 DOI: 10.3389/fonc.2023.1229936] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2023] [Accepted: 09/18/2023] [Indexed: 01/22/2024] Open
Abstract
Primary hepatic squamous cell carcinoma (SCC) is extremely rare, and only a few dozen cases have been reported to date. It can barely be diagnosed before histopathological examination, which necessitates the exclusion of metastatic tumors. In this case, we present a 60-year-old female patient with no comorbidity. As laboratory tests and imaging examinations were not diagnostic, ultrasonography (US)-guided liver biopsy was performed and eventually revealed a definitive pathological diagnosis of hepatic SCC. After excluding metastasis, the diagnosis of primary hepatic SCC was established, and then chemotherapy and immunotherapy were performed. Additionally, a comprehensive literature search was conducted on primary hepatic SCC using PubMed, Google Scholar, and Web of Science, and a total of 53 articles were retrieved with a time range from 1972 to 2022. A critical analysis was then performed to evaluate previous literature focusing on the clinical characteristics, imaging features, treatments, and prognosis.
Collapse
Affiliation(s)
- Lin Zhao
- Department of Ultrasound, The Third Central Hospital of Tianjin, Tianjin, China
- Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin Third Central Hospital, Tianjin, China
- Tianjin Institute of Hepatobiliary Disease, Tianjin Third Central Hospital, Tianjin, China
| | - Yan Zhou
- Department of Ultrasound, The Third Central Hospital of Tianjin, Tianjin, China
- Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin Third Central Hospital, Tianjin, China
- Tianjin Institute of Hepatobiliary Disease, Tianjin Third Central Hospital, Tianjin, China
| | - Jianmin Ding
- Department of Ultrasound, The Third Central Hospital of Tianjin, Tianjin, China
- Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin Third Central Hospital, Tianjin, China
- Tianjin Institute of Hepatobiliary Disease, Tianjin Third Central Hospital, Tianjin, China
| | - Zhengyi Qin
- Department of Ultrasound, The Third Central Hospital of Tianjin, Tianjin, China
- Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin Third Central Hospital, Tianjin, China
- Tianjin Institute of Hepatobiliary Disease, Tianjin Third Central Hospital, Tianjin, China
| | - Hongyu Zhou
- Department of Ultrasound, The Third Central Hospital of Tianjin, Tianjin, China
- Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin Third Central Hospital, Tianjin, China
- Tianjin Institute of Hepatobiliary Disease, Tianjin Third Central Hospital, Tianjin, China
| | - Xiang Jing
- Department of Ultrasound, The Third Central Hospital of Tianjin, Tianjin, China
- Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin Third Central Hospital, Tianjin, China
- Tianjin Institute of Hepatobiliary Disease, Tianjin Third Central Hospital, Tianjin, China
| |
Collapse
|